Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 198

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 198
---
                                            
 services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services 
 to be performed;                                                                                                                   |

| ● | appointing or replacing  
 the independent auditor; |

| ● | determining the compensation                                                                                                       
 and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent 
 auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;                    |

| ● | establishing procedures                                                                                                             
 for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports 
 which raise material issues regarding our financial statements or accounting policies; and                                          |

| ● | approving reimbursement                                                                 
 of expenses incurred by our management team in identifying potential target businesses. |

The Audit Committee is composed exclusively of “independent directors” who are “financially literate” as defined under the Nasdaq listing standards. The Nasdaq listing standards define “financially literate” as being able to read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement. Compensation Committee We have established the Compensation Committee, which is composed exclusively of independent directors consisting of Paul Field, who is the Chairman of the Compensation Committee, Charles Allen and Stephen Toovey. Each member of the Compensation Committee is a non-employee director, as defined under Rule 16b-3 promulgated under the Exchange Act, and an outside director, as defined pursuant to Section 162(m) of the Code. Our Board adopted a Compensation Committee Charter on March 16, 2023, which was deemed effective as of July 11, 2023. The Compensation Committee’s duties, which are specified in our Compensation Committee Charter, include, but are not limited to:

| ● | reviews, approves and determines, or makes recommendations          
 to our Board regarding, the compensation of our executive officers; |

| ● | administers our equity compensation plans; |

| ● | reviews and approves, or                                                                                
 makes recommendations to our Board, regarding incentive compensation and equity compensation plans; and |

| ● | establishes and reviews                                                  
 general policies relating to compensation and benefits of our employees. |

118 Nominating and Corporate Governance Committee We have established the Nominating and Corporate Governance Committee, which is composed exclusively of independent directors consisting of Stephen Toovey, who is the Chairman of the Nominating and Corporate Governance Committee, Charles Allen and Paul Field. Our Board adopted a Nominating and Corporate Governance